gene (s) .
Thus, we have tested the hypothesis that phenytoin may have similar genetic differences in susceptibility to the production of this defect in mice a s does cortisone.
Phenytoin was administered at 50 gs/kg from the 11-14 days of gestation in the strains : / J (d), B10 (d) , and BIO.A (having ! & but otherwise 99.5% of genetic background of ~1 0 ) . Susceptibility to phenytoin-induced cleft palate is high in A/J (43.8% of offspring) and BIO.A (32.9%) but low in B10 (1.6%).
Therefore, a gene controlling phenytoin-induced cleft palate is also located in or near the H-2 locus. These results give the first evidence 3f a genetic control mechanism (by a gene in or near the H-2 locus) for susceptibility to a congenital malformation (cleft palate) to a xenobiotic (phenytoin). dicine, Department of Pediatrics, Stanford, CA.
onsisting of a dark and light band. Her normal mother and a sis er each carry a 12p+ chromosome similar to that of the proband nd one chromosome 16 deficient for the segment q22+qter, inicating a balanced translocation: 46,XX,t(l2;16)(pl3;q22).
The roband inherited the maternal 12p+ chromosome and normal chromoome 16. Her karyotype is 46,XX,der12,t(12;16)(p13;q22)mat. She s trisomic for the segment of 16q22+16qter and may be monosomic or the segment 12~13. Although she has had recurrent infection ibling with dysmorphic features died in infancy of pneumonia.
The parents conceived a male child with the same unbalanced Deparment of Pathology, Boston. Acetazolamide sodium, a d i u r e t i c i n man due t o inhibition of carbonic anhydrase, produces postaxial forelimb Qfonnities i n mice when administered i n utero on days 9 o r 10 of gestation. ?he deformities a r e mud.imo~oomnon on the r i g h t side. I Ve have evaluated the p a t t e r n of mesenchyme c e l l aggregation and c a r t ilage formation i n day ll!i t o 124 f o r e l i d s of C57BL/6J enbryos, a s t r a i n known t o be susceptible t o t h i s teratogen (Teratology 11:37, 1975 The remaining aggregates showed normal p a t t e r n s of c e l l p o l a r i t y , a s deternulled by staining t h e Golgi apparatus with s i l v e r n i t r a t e and determining the o r i e n t a t i o n of t h e stained mesenchyme c e l l s tmarcl the center of the aggregate. The mechanism of action of acetazolamide i s not known. These studies suggest t h a t i t i n t e r f e r e s with e a r l y mesenchyme c e l l aggregation i n a r es t r i c t e d anatomic region presumably by interrupting t h e n o n a l process of c e l l -t o -c e l l adhesion.
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INFANTS? Barry J. Maron, Jesse E. Edwards, Stephen E. Epstein. National Heart, Lung, and Blood Institute, Bethesda Md.
Disproportionate septa1 thickening (DST) (septal-free wall thickness ratio 21.3) is the most characteristic anatomic feature of hypertrophic cardiomyopathy (HCM). To assess prevalence of DST in infants with congenital heart diseases, and to determine whether septal-free wall ratio 21.3 should be utilized as the diagnostic criteria of DST in infancy (when absolute wall thicknesses are small), 129 patients <2 yrs old were studied at necropsy. DST was present in 33 (25%) of 129 patients; in these patients septal-free wall ratios ranged from 1.3-2.5 but were 51.7 in 32. DST was not common in patients with any particular cardiac malformation. Of note, if a septalfree wall ratio 3 . 5 was used as the criteria for DST, only 7% of patients were abnormal. In only 3 of 33 patients with septalfree wall ratio >1.3 was marked disorganization of septal myocardium, characteristic of HCM, present. Hence: 1) DST is common in infants with congenital heart diseases studied at necropsy; 2) the vast majority of such patients with septal-free wall ratios of y . 3 do not have typical necropsy findings of HCM, since disorganization of septal myocardium is rarely present; and 3) septal-free wall ratio 3 . 3 alone is not reliable in identifying associated HCM in infants with congenital heart disease, especially if marked absolute septal thickening or disorganization of septal myocardium are absent. Puncture of the fetal membranes was performed on rat fetuses during the last third of gestation; the puncture was considered adequate when withdrawal of the needle was followed by continued leakage of amniotic fluid.
SELECTIVE PARENCHYMAL GROWTH RETARDATION IN
All animals (n=54) were allowed to develop until term and were delivered abdominally, the littermates serving as controls (~84). Weights and measurements of the fetus, placenta and various organs were recorded. Total lung DNA, RNA and protein were determined in 14 treated and control ani.
nals. The length of the umbilical cord was mukedly reduced in the experi; mental group, (~<0.001). Lung weight and lung/body ratio were lower in 'he treated animals, (K0.001). Total lung DNA was significantly less in the treated animals, confirming lung hypoplasia. RNA/DNA and protein/ DNA ratios were not affected, indicating that cell size remained constant.
The ~atho~enetic mechanism leading to hypoplasia appears different from that observed in models of utero-placental insufficiency since the brain/ liver ratio was not affected. The same pattern of selective parenchymal growth retardation was noted in 7 newborn infants with documented oligoqydramnios. In addition, congenital deformities resembling those seen in infantsborn after prolonged oligohydrarnnias were noted in the treated animals. This model should prove useful to clarify the pathogenesis of the aligohydramnios syndrome and lung hypoplasia, and to study the kinetics of lung catch-up growth.
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